コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 Its antibacterial activity is limited to gram positive bacteria.
2 ase probe in B. subtilis and closely related gram positive bacteria.
3 bility in a wider range of Gram negative and Gram positive bacteria.
4 covalently attached to the peptidoglycan of gram positive bacteria.
5 ss regulator Spx is ubiquitously found among Gram-positive bacteria.
6 elements are now thought to occur widely in gram-positive bacteria.
7 elevant for the killing of Gram-negative and Gram-positive bacteria.
8 tic with rapid bactericidal activity against gram-positive bacteria.
9 yclic depsipeptide antibiotic active against Gram-positive bacteria.
10 , but they are ineffective against resistant gram-positive bacteria.
11 est basins displayed an increase in only the gram-positive bacteria.
12 nst fluoroquinolone resistant MRSA and other Gram-positive bacteria.
13 cell wall biosynthesis and pathogenicity in Gram-positive bacteria.
14 le is known about flagellin glycosylation in Gram-positive bacteria.
15 tibiotics, which inhibit the growth of other Gram-positive bacteria.
16 ins to the peptidoglycan of the cell wall of gram-positive bacteria.
17 y key roles in several cellular processes in Gram-positive bacteria.
18 nctionalize the peptidoglycan layers of many Gram-positive bacteria.
19 ed in PHPT homologues from Gram-negative and Gram-positive bacteria.
20 ons caused by Staphylococcus aureus or other Gram-positive bacteria.
21 ning a new mechanism of protein anchoring in Gram-positive bacteria.
22 h regulates many amino acid-related genes in Gram-positive bacteria.
23 s and is known to possess selectivity toward Gram-positive bacteria.
24 e essential for function and conserved among Gram-positive bacteria.
25 ) is an important cell wall polymer found in gram-positive bacteria.
26 broad scope of activities against different Gram-positive bacteria.
27 nent required for proper cell growth in many Gram-positive bacteria.
28 es level differentiation of the investigated Gram-positive bacteria.
29 copeptide with bactericidal activity against gram-positive bacteria.
30 enuate the inflammatory responses induced by Gram-positive bacteria.
31 crobial activity against S. aureus and other Gram-positive bacteria.
32 conditions and many preferentially targeting Gram-positive bacteria.
33 to catalyze both reactions of the process in Gram-positive bacteria.
34 and subsequent release of vesicular cargo in Gram-positive bacteria.
35 ster units that are found in the envelope of Gram-positive bacteria.
36 ntier that has been investigated in only few Gram-positive bacteria.
37 secretion systems in many Gram-negative and Gram-positive bacteria.
38 (LTA) is an important cell wall component of Gram-positive bacteria.
39 e editing in lactic acid bacteria, and other Gram-positive bacteria.
40 is induced by STAT3 signaling in response to Gram-positive bacteria.
41 les were effective against gram-negative and gram-positive bacteria.
42 omplementing the method's proven utility for Gram-positive bacteria.
43 tative antimicrobial activity mainly against Gram-positive bacteria.
44 hrough amelioration of the disease burden of gram-positive bacteria.
45 s antimicrobial activity and selectivity for Gram-positive bacteria.
46 nvolved in protein quality control in low-GC Gram-positive bacteria.
47 rom positive blood culture broths containing Gram-positive bacteria.
48 .3% for Gram-negative bacteria and 98.3% for Gram-positive bacteria.
49 hila model of infection when cocultured with Gram-positive bacteria.
50 ring elongation in rod-shaped and ovococcoid Gram-positive bacteria.
51 occurs at spatially restricted foci in some Gram-positive bacteria.
52 ited potent antimicrobial properties against Gram-positive bacteria.
53 reaction that is essential for the growth of gram-positive bacteria.
54 by multiple lantibiotics produced by diverse Gram-positive bacteria.
55 ence proteins have so far been restricted to Gram-positive bacteria.
56 P family (for Rap, NprR, PrgX, and PlcR), in Gram-positive bacteria.
57 ays enhanced virulence during coculture with Gram-positive bacteria.
58 in Siphoviridae infecting a wide variety of Gram-positive bacteria.
59 genes) in a large group of phages infecting Gram-positive bacteria.
60 tive matrix - the first such observation for Gram-positive bacteria.
61 ll components such as lipoteichoic acid from Gram-positive bacteria.
62 eux, Inc.) for the identification of aerobic Gram-positive bacteria.
63 of a detrimental outcome from pneumonia with Gram-positive bacteria.
64 teichoic acid (WTA) to the peptidoglycan of Gram-positive bacteria.
65 represent a novel type of oxidoreductase in Gram-positive bacteria.
66 rowth inhibitory effect in Gram-negative and Gram-positive bacteria.
67 ins play a crucial role in virulence in some gram-positive bacteria.
68 whose hosts are Bacillus cereus and related Gram-positive bacteria.
69 dable in vitro activity against a variety of Gram-positive bacteria.
70 oups by their hosts, either Gram-negative or Gram-positive bacteria.
71 xhibits potent antimicrobial effects against Gram-positive bacteria.
72 iscuous plasmids and their preference toward Gram-positive bacteria.
73 tial target for evaluating antimicrobials in gram-positive bacteria.
74 anding the biology of tectiviruses infecting Gram-positive bacteria.
75 hat displays nanomolar activity against many Gram-positive bacteria.
76 e opposite trend was observed in the case of Gram-positive bacteria.
77 vidin, recognizing almost none of the tested Gram-positive bacteria.
78 obal regulator of transcription in low G + C Gram-positive bacteria.
79 wn function that is well conserved in low-GC Gram-positive bacteria.
80 he CTC protein, a feature typical to various Gram-positive bacteria.
81 ive peptide/protein pairs we engineered from Gram-positive bacteria.
82 wn tropism of RNA bacteriophages may include gram-positive bacteria.
83 nificant antimicrobial effect, especially in gram-positive bacteria.
84 uses (bacteriophages) specifically infecting Gram-positive bacteria.
85 izes many types of PAMPs that originate from gram-positive bacteria.
86 peptides, and vulnerability to infection by Gram-positive bacteria.
87 epeat glycoproteins (SRRPs) are conserved in Gram-positive bacteria.
88 ich is linked to cell growth and division in Gram-positive bacteria.
89 , Staphylococci, and Streptococci, and other Gram-positive bacteria.
90 ates initiation of DNA replication in low-GC Gram-positive bacteria.
91 The most commonly identified organisms were gram-positive bacteria.
92 negative bacteria, but neither is present in Gram-positive bacteria.
93 gh which the stringent response functions in Gram-positive bacteria.
94 ossessed weak antibacterial activity against Gram-positive bacteria.
96 fective drug target for resistant strains of Gram-positive bacteria.2 In addition, because sortase A
100 16S rRNA gene pyrosequencing showed that Gram-positive bacteria affiliated with the Firmicutes an
101 ting the translocation of selected arrays of Gram-positive bacteria against which the host mounts eff
102 or of coproporphyrinogen oxidase (CgoX) from Gram-positive bacteria, an enzyme essential for heme bio
103 tase, a cysteine-transpeptidase conserved in Gram-positive bacteria, anchors on the cell wall many su
104 representative of monomeric RmlD enzymes in Gram-positive bacteria and a subset of Gram-negative bac
106 the formation of competence-induced pili in Gram-positive bacteria and corroborate the remarkable st
109 biosensors for in vivo metabolite imaging in Gram-positive bacteria and have validated the first dinu
112 is present in a subset of gram-negative and gram-positive bacteria and is the founding member of a n
113 uld be used for the quantitative analysis of Gram-positive bacteria and might be applied potentially
114 inhibited the growth of antibiotic-resistant gram-positive bacteria and prolonged the survival of mic
115 youngest basins had increased abundances of gram-positive bacteria and saprotrophic fungi at higher
116 us of Zg16(-/-) animals had a higher load of Gram-positive bacteria and showed bacteria with higher m
117 rganisms (like plants and cyanobacteria), in Gram-positive bacteria, and a few other bacterial phyla.
118 is a recently identified endoribonuclease in Gram-positive bacteria, and an RNase Y ortholog has been
119 e reductase) protein family, is conserved in Gram-positive bacteria, and interacts with RNA polymeras
120 es an overview of RNA-mediated regulation in Gram-positive bacteria, and is highlighted with specific
122 gram-negative bacteria, lipoteichoic acid in gram-positive bacteria, and phospholipomannan in fungi.
123 served yet uncharacterized proteins found in Gram-positive bacteria, and they shed new light on the r
124 protein family, which is spread widely among gram-positive bacteria; and suggests approaches to targe
125 gram-negative bacteria, infections caused by gram-positive bacteria, antimicrobial stewardship and in
129 ng adhesive matrix molecules (MSCRAMMs) from Gram-positive bacteria are established virulence factors
132 However, the mechanisms of MV formation in Gram-positive bacteria are unclear, as these cells posse
133 obacteria and Firmicutes (high-GC and low-GC Gram-positive bacteria) are unable to synthesize protopo
134 on, P. aeruginosa uses peptidoglycan shed by Gram-positive bacteria as a cue to stimulate production
135 anscription in innate immunity, and identify Gram-positive bacteria as extracellular stimuli of Hippo
138 n shows broad antibacterial activity against Gram-positive bacteria, but is also hemolytic and cytoto
139 ions and is evolutionarily conserved in many Gram-positive bacteria, but its function in M. tuberculo
140 er regulator of carbon source utilization in gram-positive bacteria, but the CcpA regulon remains ill
146 The serine-rich repeat glycoproteins of Gram-positive bacteria comprise a large family of cell w
147 al functions of specific compounds, and that Gram-positive bacteria considered to be obligate aerobes
148 oteichoic acid (LTA), a cell wall polymer of gram-positive bacteria, consists of 1,3-polyglycerol-pho
153 the B16-OVA melanoma model and an optimized Gram-positive bacteria-dendritic cell (DC) vaccination s
155 th antibiotics that target Gram-negative and Gram-positive bacteria develop ameliorated psoriasiform
156 call NDA-1, contributes to the reduction of Gram-positive bacteria during early development and thus
158 ies have shown that ADEPs are active against Gram-positive bacteria (e.g., MRSA, VRE, PRSP (penicilli
159 polyisoprenoid biosynthesis, is essential in Gram-positive bacteria (e.g., Staphylococcus, Streptococ
160 itory concentration (MIC) was much lower for Gram positive bacteria (Enterococcus spp. and Staphyloco
162 oronate chemistry allows potent labelling of Gram-positive bacteria even in the presence of 10% serum
164 e to certain members of the low-G+C group of Gram-positive bacteria (Firmicutes) and requires signatu
165 amined PrsA proteins encoded by a variety of Gram-positive bacteria for functional complementation of
167 ased on self-assembly of vancomycin (Van) on Gram-positive bacteria for imaging bacterial infection.
168 doxin reductase, a protein essential in many Gram-positive bacteria for maintaining the thiol-redox b
170 ficiently removes multiple Gram-negative and Gram-positive bacteria, fungi and endotoxins from whole
171 peptide sensor to various concentrations of Gram-positive bacteria generated reproducible impedance
173 ding Eukaryota, Homo sapiens, Viridiplantae, Gram-positive Bacteria, Gram-negative Bacteria and Virus
174 numerous antibiotic resistance plasmids from Gram-positive bacteria, Gram-negative phage and the mobi
177 though riboflavin precursor derivatives from Gram-positive bacteria have been characterized, some lev
179 ickness can vary greatly among species, with Gram-positive bacteria having a thicker wall than Gram-n
181 iotic resistance in bacteria have focused on Gram-positive bacteria; however, multidrug-resistant Gra
185 Mycobacterium tuberculosis, are unique among Gram-positive bacteria in producing a complex cell wall
186 hydrochalcones are able to inhibit growth of Gram positive bacteria, in particular Staphylococcus aur
187 a in the phylum Firmicutes (formerly low-G+C Gram-positive bacteria) includes diverse bacteria of med
188 antibiotic with activity against a range of Gram-positive bacteria including drug-resistant pathogen
189 The lantibiotic NAI-107 is active against Gram-positive bacteria including vancomycin-resistant en
190 found that auranofin is active against other Gram-positive bacteria, including Bacillus subtilis and
191 shown to play a role in the pathogenesis of Gram-positive bacteria, including E. faecium We previous
192 psin was bactericidal against a diversity of Gram-positive bacteria, including human pathogens such a
193 aining domains are unexpectedly prevalent in Gram-positive bacteria, including many clinically releva
194 crobial activity against multidrug-resistant Gram-positive bacteria, including MRSA and VRE, rapid ti
195 The obtained compounds were active against Gram-positive bacteria, including multiresistant Staphyl
197 ial activity against model Gram negative and Gram positive bacteria is reported for selected compound
199 at cyclic-di-adenosine monophosphate in live Gram-positive bacteria is a vita-PAMP, engaging the inna
201 c IgG booster responses to Gram-negative and Gram-positive bacteria is contained solely within the B
202 Surface display of proteins by sortases in Gram-positive bacteria is crucial for bacterial fitness
204 However, iron-sulfur cluster biogenesis in Gram-positive bacteria is not so well characterized, and
205 that acidification of phagosomes containing Gram-positive bacteria is regulated by the NLRP3 inflamm
206 or example, increasing drug resistance among gram-positive bacteria is responsible for approximately
209 d cell shape, and, in the case of pathogenic Gram-positive bacteria, it lies at the interface between
212 in mechanism of action on gram-negative and gram-positive bacteria may be less pronounced than forme
214 Furthermore, the pilus shaft assembly in Gram-positive bacteria may require a tip, as is true for
215 elated wall-associated protein A (WapA) from Gram-positive bacteria mediate intercellular competition
216 uggest that therapeutic strategies targeting Gram-positive bacteria might be a viable approach for re
218 t activity and antibacterial effects against Gram-positive bacteria, namely methicillin-susceptible S
219 1,157) of single-organism cultures contained Gram-positive bacteria not present on the BC-GP test pan
220 sensitive and resistant Gram-negative and/or Gram-positive bacteria of new amphiphilic 3',4'-dialkyl
223 Little is known about their formation in Gram-positive bacteria, particularly among facultative a
228 and inhibits cell wall biosynthesis in other Gram-positive bacteria probably by binding to lipid II,
229 bernation promoting factor (HPF), while most Gram-positive bacteria produce a single, longer HPF prot
230 here enhances our understanding of how other Gram-positive bacteria produce essential components of t
233 role in CMP-pseudaminic acid biosynthesis in Gram-positive bacteria provides a foundation to investig
234 function are broadly conserved among diverse Gram-positive bacteria, PrsA2 exhibits unique specificit
236 of infections caused by antibiotic-resistant gram-positive bacteria requires the discovery of new dru
237 Type VII protein secretion system, found in Gram-positive bacteria, secretes small proteins, contain
238 are gene-regulatory mRNA elements with which Gram-positive bacteria sense amino acid availability.
239 basis for formation of the 100S complexes in Gram-positive bacteria, shedding light on the mechanism
240 al strains, including both Gram-negative and Gram-positive bacteria, showing great potential for appl
241 cond messenger predicted to be widespread in Gram-positive bacteria, some Gram-negative bacteria, and
244 rhinosinusitis (CRS) has been linked to the gram-positive bacteria Staphylococcus aureus (S. aureus)
246 cytokine mRNA expression in response to the Gram-positive bacteria Streptococcus pneumoniae and Stap
248 of complement by FH6-7/Fc on the surface of Gram-positive bacteria such as S. pyogenes will enable p
250 oro derivative that retains activity against Gram-positive bacteria, such as anthrax, but also shows
252 s exhibited antibacterial activities against gram-positive bacteria, such as Bacillus subtilis and St
254 ied in multiple pilus gene clusters of other Gram-positive bacteria, suggesting that similar signalin
257 Nocardia exalbida, all the other 725 (99.7%) gram-positive bacteria tested were susceptible to vancom
260 treptococcus agalactiae) are beta-hemolytic, Gram-positive bacteria that are common asymptomatic colo
261 TA) is a major component of the cell wall of Gram-positive bacteria that can trigger inflammatory res
262 Streptococcus agalactiae are beta-hemolytic gram-positive bacteria that colonize the lower genital t
263 enzyme superfamily are widely distributed in Gram-positive bacteria that frequently utilize multiple
265 ied by sequence similarity in the genomes of Gram-positive bacteria that possess IsdG-family heme oxy
266 Bacilli are ubiquitous low G+C environmental Gram-positive bacteria that produce a wide assortment of
267 environmental conditions, including, within Gram-positive bacteria, the stressosome complex that reg
268 tibody-conjugated AuNPs can readily identify Gram-positive bacteria through antibody-antigen recognit
270 rticles (AuNP) modified with monoclonal anti-Gram-positive bacteria to produce an immune-sensor.
271 iffuse more easily into porous cell walls of Gram-positive bacteria to reach sensitive sites, while t
273 The more penetrable Zg16(-/-) mucus allowed Gram-positive bacteria to translocate to systemic tissue
282 viously, extracellular vesicle production in Gram-positive bacteria was dismissed due to the absence
283 iation of the gene with heme biosynthesis in Gram-positive bacteria was previously demonstrated by ex
285 ogy between MurJ and putative orthologs from Gram-positive bacteria, we explored the conservation of
292 istributed among different gram-negative and gram-positive bacteria, where they act as pathogenicity
293 a extracts were more effective in inhibiting Gram-positive bacteria while soybean extract exhibited s
294 oncentrations in different Gram-negative and Gram-positive bacteria, while its hemolytic activity rem
295 These adhesives kill both Gram-negative and Gram-positive bacteria, while sparing human erythrocytes
296 glycopolymers found on the cell wall of many Gram-positive bacteria, whose diverse surface structures
298 pound also has high antibacterial potency on Gram-positive bacteria with an MIC versus wild type S. a
300 edicine and nanotechnology.It is unclear how Gram-positive bacteria, with a thick cell wall, can rele
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。